NEJM Evidence has graciously made our recent paper, “Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes,” open access so that anyone can read and download it for free. As described in more detail in my blog post on the paper, it uses data from 107 population epidemiology studies of the association between e-cigaretteContinue reading “NOW OPEN ACCESS: E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone”
Tag Archives: news
Contrary to public position, Juul founders wanted to attract former and non-smokers from the beginning
Juul co-founders Adam Monsees and James Bowen portray themselves as idealistic entrepreneurs committed to improving the health of billions of adult smokers with no intent to sell nicotine to non-smokers. Documents released as part of the settlement of North Carolina’s lawsuit against Juul, however, tells quite a different story. In particular, Monsees & Bowen’s 2006Continue reading “Contrary to public position, Juul founders wanted to attract former and non-smokers from the beginning”
More information on how ecigs increase cardiovascular disease risk
The evidence that e-cigarette use is associated with increased cardiovascular disease keeps accumulaing, together with studies on the specific pathophysiological mechanisms through which e-cigarette use increases disease risk. The recent review by Huiqi Zong, Zhekai Hu and colleagues, Electronic cigarettes and cardiovascular disease: epidemiological and biological links, is the most recent summary of this evidence.Continue reading “More information on how ecigs increase cardiovascular disease risk”
FDA needs to reconsider its promotion of the “continuum of risk” for e-cigarettes
As of February 22, 2024, the FDA was continuing to embrace the idea that there is a “continuum of risk” with combusted tobacco as the riskiest and e-cigarettes being substantially less risky. As a result, FDA promotes e-cigarettes as a way for smokers to reduce risk. This view is based on the fact that e-cigarettesContinue reading “FDA needs to reconsider its promotion of the “continuum of risk” for e-cigarettes”
E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone
It is an article of faith among e-cigarette advocates that they are substantially less risky than cigarettes. Rather than being based on the actual associations between e-cigarette use and disease, this belief is based on the fact that e-cigarettes do not burn tobacco, so avoid the toxic combustion products that cigarettes produce. In recent years,Continue reading “E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone”
Banning menthol leads a quarter of menthol smokers to quit
The two justifications for the FDA’s proposed product standard prohibiting menthol cigarettes and cigars are (1) it will reduce youth initiation, and (2) it will help menthol smokers to quit. Now Sarah Mills and colleagues have published a review and meta-analysis of the effects of menthol bans around the world, The Impact of Menthol CigaretteContinue reading “Banning menthol leads a quarter of menthol smokers to quit”
Relevant to COP10: Pharmaceuticalisation as the tobacco industry’s endgame
Yogi Hendlin, Eileen Han and Pam Ling’s new paper Pharmaceuticalisation as the tobacco industry’s endgame provides a detailed analysis of how the multinational tobacco companies have developed and used the companies efforts to reposition themselves a source for “clean” nicotine while simultaneously maintaining and expanding their sales of cigarettes and other “traditional” tobacco products whereContinue reading “Relevant to COP10: Pharmaceuticalisation as the tobacco industry’s endgame”
COP10 delegates need to base decisions on latest e-cig evidence, not the same old studies e-cig advocates promote
In the lead up to the WHO Framework Convention on Tobacco Control Tenth Conference of the Parties that starts today, advocates for e-cigarettes and other “reduced harm” tobacco products have been busy again arguing that delegates should embrace these products. In reviewing some of this material, I have been struck by the fact that theirContinue reading “COP10 delegates need to base decisions on latest e-cig evidence, not the same old studies e-cig advocates promote”
Youth living in vapefree homes much less likely to use e-cigs
While the reason for enacting smokefree laws and implementing voluntary smokefree policies has been to protect people from secondhand smoke, a well-established side effect is that they help adult smokers quit and help prevent youth smoking (laws, home policies). Now Jeremy Staff and his colleagues have shown that kids living in vapefree households are muchContinue reading “Youth living in vapefree homes much less likely to use e-cigs”
Ecigs increased health costs by $15.1 billion in 2018
Until now we have not had direct estimates of the costs of treating the excess disease that e-cigarettes cause. Now, Yingning Wang and her UCSF colleagues have published Healthcare utilisation and expenditures attributable to current e-cigarette use among US adults that applies the same well-established methods they have used to estimate the medical costs of smokingContinue reading “Ecigs increased health costs by $15.1 billion in 2018”
Stanton Glantz blog 